3 Small-Cap Biotech Stocks That Are Challenging the Status Quo
WHITEFISH, MT / ACCESSWIRE / June 29, 2015 / Small-cap biotech stocks have been top performers so far this year, with the PowerShares S&P SmallCap Healthcare ETF (PSCH) returning 25%, which is 5x better than the SPDR S&P 500 ETF’s (NYSE:SPY) 5% return. Investors may want to consider adding exposure to this asset class given its outperformance and lower correlation with the overall U.S. equity market.